Light induced cytosolic drug delivery from liposomes with gold nanoparticles.

Externally triggered drug release at defined targets allows site- and time-controlled drug treatment regimens. We have developed liposomal drug carriers with encapsulated gold nanoparticles for triggered drug release. Light energy is converted to heat in the gold nanoparticles and released to the lipid bilayers. Localized temperature increase renders liposomal bilayers to be leaky and triggers drug release. The aim of this study was to develop a drug releasing system capable of releasing its cargo to cell cytosol upon triggering with visible and near infrared light signals. The liposomes were formulated using either heat-sensitive or heat- and pH-sensitive lipid compositions with star or rod shaped gold nanoparticles. Encapsulated fluorescent probe, calcein, was released from the liposomes after exposure to the light. In addition, the pH-sensitive formulations showed a faster drug release in acidic conditions than in neutral conditions. The liposomes were internalized into human retinal pigment epithelial cells (ARPE-19) and human umbilical vein endothelial cells (HUVECs) and did not show any cellular toxicity. The light induced cytosolic delivery of calcein from the gold nanoparticle containing liposomes was shown, whereas no cytosolic release was seen without light induction or without gold nanoparticles in the liposomes. The light activated liposome formulations showed a controlled content release to the cellular cytosol at a specific location and time. Triggering with visual and near infrared light allows good tissue penetration and safety, and the pH-sensitive liposomes may enable selective drug release in the intracellular acidic compartments (endosomes, lysosomes). Thus, light activated liposomes with gold nanoparticles are an attractive option for time- and site-specific drug delivery into the target cells.

[1]  H Lenz,et al.  Measurements on the depth of penetration of light (0.35–1.0 µm) in tissue , 1977, Radiation and environmental biophysics.

[2]  Lin Zhu,et al.  Targeted delivery of methotrexate to skeletal muscular tissue by thermosensitive magnetoliposomes. , 2009, International journal of pharmaceutics.

[3]  Choon Nam Ong,et al.  Gold Nanoparticles Induce Oxidative Damage in Lung Fibroblasts In Vitro , 2008 .

[4]  Xiaohu Gao,et al.  Spectrally tunable leakage-free gold nanocontainers. , 2009, Journal of the American Chemical Society.

[5]  F. Szoka,et al.  Efficiency of Cytoplasmic Delivery by pH-Sensitive Liposomes to Cells in Culture , 1990, Pharmaceutical Research.

[6]  C. Plank,et al.  Application of membrane-active peptides for drug and gene delivery across cellular membranes. , 1998, Advanced drug delivery reviews.

[7]  David H Sliney,et al.  Maximum permissible exposures for ocular safety (ANSI 2000), with emphasis on ophthalmic devices. , 2007, Journal of the Optical Society of America. A, Optics, image science, and vision.

[8]  J. Hafner,et al.  Plasmon resonances of a gold nanostar. , 2007, Nano letters.

[9]  Stephan Link,et al.  Size and temperature dependence of the plasmon absorption of colloidal gold nanoparticles , 1999 .

[10]  Sung-Hee Park,et al.  Loading of gold nanoparticles inside the DPPC bilayers of liposome and their effects on membrane fluidities. , 2006, Colloids and surfaces. B, Biointerfaces.

[11]  Wah Chiu,et al.  Remotely triggered liposome release by near-infrared light absorption via hollow gold nanoshells. , 2008, Journal of the American Chemical Society.

[12]  K. Edwards,et al.  Use of a passive equilibration methodology to encapsulate cisplatin into preformed thermosensitive liposomes. , 2008, International journal of pharmaceutics.

[13]  W. Hennink,et al.  Temperature-sensitive poly(N-(2-hydroxypropyl)methacrylamide mono/dilactate)-coated liposomes for triggered contents release. , 2007, Bioconjugate chemistry.

[14]  C. Murphy,et al.  Gold nanoparticles are taken up by human cells but do not cause acute cytotoxicity. , 2005, Small.

[15]  J. Heller,et al.  Development of enzymatically degradable protective coatings for use in triggered drug delivery systems: derivatized starch hydrogels. , 1990, Biomaterials.

[16]  G. Gregoriadis,et al.  Effect of the cholesterol content of small unilamellar liposomes on their stability in vivo and in vitro. , 1980, The Biochemical journal.

[17]  C. Harding,et al.  Processing of exogenous liposome-encapsulated antigens in vivo generates class I MHC-restricted T cell responses. , 1992, Journal of immunology.

[18]  Michael J Ford,et al.  Optimization of plasmonic heating by gold nanospheres and nanoshells. , 2006, The journal of physical chemistry. B.

[19]  P. Kaufman,et al.  Effects of retinal ganglion cell loss on magno-, parvo-, koniocellular pathways in the lateral geniculate nucleus and visual cortex in glaucoma , 2003, Progress in Retinal and Eye Research.

[20]  D. Bok,et al.  Practical Remarks on Gout, Rheumatic Fever, and Chonic Rheumatism of the Joints; Being the Substance of the Croonian Lectures for the Present Year, Delivered at the College of Physicians , 1844, Edinburgh Medical and Surgical Journal.

[21]  L. Liz‐Marzán,et al.  High-yield synthesis and optical response of gold nanostars , 2008, Nanotechnology.

[22]  David A Jaffray,et al.  Cellular uptake and transport of gold nanoparticles incorporated in a liposomal carrier. , 2010, Nanomedicine : nanotechnology, biology, and medicine.

[23]  Shyh-Dar Li,et al.  Thermosensitive liposomes for the delivery of gemcitabine and oxaliplatin to tumors. , 2013, Molecular pharmaceutics.

[24]  K. Edwards,et al.  Encapsulation of doxorubicin into thermosensitive liposomes via complexation with the transition metal manganese. , 2005, Journal of controlled release : official journal of the Controlled Release Society.

[25]  Sérgio Simões,et al.  On the formulation of pH-sensitive liposomes with long circulation times. , 2004, Advanced drug delivery reviews.

[26]  D. Friend,et al.  Endocytosis of liposomes and intracellular fate of encapsulated molecules: Encounter with a low pH compartment after internalization in coated vesicles , 1983, Cell.

[27]  A. Quantock,et al.  Light transmission in the human cornea as a function of position across the ocular surface: theoretical and experimental aspects. , 2008, Biophysical journal.

[28]  A. Bunker,et al.  Study of PEGylated lipid layers as a model for PEGylated liposome surfaces: molecular dynamics simulation and Langmuir monolayer studies. , 2011, Langmuir : the ACS journal of surfaces and colloids.

[29]  J. V. van Best,et al.  Light transmission of the cornea in whole human eyes. , 1990, Experimental eye research.

[30]  K. Maruyama,et al.  Enhanced delivery of doxorubicin to tumor by long-circulating thermosensitive liposomes and local hyperthermia. , 1993, Biochimica et biophysica acta.

[31]  Jennifer K Barton,et al.  Biodegradable Plasmon Resonant Nanoshells , 2008, Advanced materials.

[32]  Brian P. Timko,et al.  Remotely Triggerable Drug Delivery Systems , 2010, Advanced materials.

[33]  Juewen Liu,et al.  Stimuli-responsive releasing of gold nanoparticles and liposomes from aptamer-functionalized hydrogels , 2011, Nanotechnology.

[34]  S. Simões,et al.  Sterically Stabilized pH-sensitive Liposomes , 1997, The Journal of Biological Chemistry.

[35]  Wenjin Guo,et al.  Characterization of a novel diolein-based LPDII vector for gene delivery. , 2002, Journal of controlled release : official journal of the Controlled Release Society.

[36]  Henk Spekreijse,et al.  UvA-DARE ( Digital Academic Repository ) Near infrared light absorption in the human eye media , 2022 .

[37]  Bong Hyun Chung,et al.  Acute toxicity and pharmacokinetics of 13 nm-sized PEG-coated gold nanoparticles. , 2009, Toxicology and applied pharmacology.

[38]  Jess P. Wilcoxon,et al.  Photoluminescence from nanosize gold clusters , 1998 .

[39]  J. Folk,et al.  Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome. , 1996, Ophthalmology.

[40]  Andreas Kornowski,et al.  Tuning size and sensing properties in colloidal gold nanostars. , 2010, Langmuir : the ACS journal of surfaces and colloids.

[41]  P. Laurinmäki,et al.  Gold-embedded photosensitive liposomes for drug delivery: triggering mechanism and intracellular release. , 2010, Journal of controlled release : official journal of the Controlled Release Society.

[42]  W. Mieler,et al.  Long-term follow-up of acute multifocal posterior placoid pigment epitheliopathy. , 1989, The British journal of ophthalmology.

[43]  K. Edwards,et al.  Disc formation in cholesterol-free liposomes during phase transition. , 2003, Biochimica et biophysica acta.

[44]  Sonia H Yoo,et al.  Age-related macular degeneration: etiology, pathogenesis, and therapeutic strategies. , 2003, Survey of ophthalmology.

[45]  J. Kost,et al.  Ultrasound, liposomes, and drug delivery: principles for using ultrasound to control the release of drugs from liposomes. , 2009, Chemistry and physics of lipids.

[46]  R. Blumenthal,et al.  Design of liposomes containing photopolymerizable phospholipids for triggered release of contents , 2009, Journal of thermal analysis and calorimetry.

[47]  Hitoshi Sato,et al.  Release of 5-fluorouracil from thermosensitive magnetoliposomes induced by an electromagnetic field , 1997 .

[48]  V. Torchilin Recent advances with liposomes as pharmaceutical carriers , 2005, Nature Reviews Drug Discovery.

[49]  Younan Xia,et al.  Gold nanocages covered by smart polymers for controlled release with near-infrared light , 2009, Nature materials.

[50]  Olaf Strauss,et al.  The retinal pigment epithelium in visual function. , 2005, Physiological reviews.

[51]  W. T. Ham,et al.  The loss of light energy in retina and choroid. , 1960, Archives of ophthalmology.

[52]  Y. Oh,et al.  Antitumor activity of EGFR targeted pH-sensitive immunoliposomes encapsulating gemcitabine in A549 xenograft nude mice. , 2009, Journal of controlled release : official journal of the Controlled Release Society.

[53]  R. Ellsworth,et al.  Unilateral vs. bilateral retinoblastoma. Correlations between age at diagnosis and stage of ocular disease. , 1986, Ophthalmology.

[54]  M. Spitznas Pathogenesis of central serous retinopathy: A new working hypothesis , 2005, Graefe's Archive for Clinical and Experimental Ophthalmology.

[55]  Alexander L. Klibanov,et al.  Microbubbles in ultrasound-triggered drug and gene delivery. , 2008, Advanced drug delivery reviews.

[56]  A. Urtti,et al.  Current and future ophthalmic drug delivery systems. A shift to the posterior segment. , 2008, Drug discovery today.

[57]  E. Antunes,et al.  Synthesis of phthalocyanine conjugates with gold nanoparticles and liposomes for photodynamic therapy. , 2012, Journal of photochemistry and photobiology. B, Biology.

[58]  J. Gass,et al.  Multifocal choroiditis and choroidal neovascularization associated with the multiple evanescent white dot and acute idiopathic blind spot enlargement syndrome. , 1992, Ophthalmology.

[59]  Alaaldin M. Alkilany,et al.  Gold nanoparticles in biology: beyond toxicity to cellular imaging. , 2008, Accounts of chemical research.

[60]  Wenjin Guo,et al.  Incorporation of reversibly cross-linked polyplexes into LPDII vectors for gene delivery. , 2002, Bioconjugate chemistry.

[61]  P. Mitchell,et al.  Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial , 2007, The Lancet.

[62]  Paresh Chandra Ray,et al.  Challenge in Understanding Size and Shape Dependent Toxicity of Gold Nanomaterials in Human Skin Keratinocytes. , 2008, Chemical physics letters.

[63]  Huanjun Chen,et al.  In vitro effect of CTAB- and PEG-coated gold nanorods on the induction of eryptosis/erythroptosis in human erythrocytes , 2012, Nanotoxicology.

[64]  G. Rapp,et al.  Structure of the stable and metastable ripple phase of dipalmitoylphosphatidylcholine , 1996, European Biophysics Journal.

[65]  M. Dellian,et al.  Novel Temperature-Sensitive Liposomes with Prolonged Circulation Time , 2004, Clinical Cancer Research.

[66]  David H. Thompson,et al.  Phototriggering of liposomal drug delivery systems. , 2001, Advanced drug delivery reviews.

[67]  H. Okada,et al.  Topical drug delivery to retinal pigment epithelium with microfluidizer produced small liposomes. , 2014, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[68]  P. Jain,et al.  Calculated absorption and scattering properties of gold nanoparticles of different size, shape, and composition: applications in biological imaging and biomedicine. , 2006, The journal of physical chemistry. B.

[69]  P. McDonnell,et al.  Nanoparticle diffusion in, and microrheology of, the bovine vitreous ex vivo. , 2013, Journal of controlled release : official journal of the Controlled Release Society.

[70]  Timo Laaksonen,et al.  Gold nanoparticles enable selective light-induced contents release from liposomes. , 2007, Journal of controlled release : official journal of the Controlled Release Society.

[71]  L. Medina-Kauwe,et al.  Intracellular trafficking of nonviral vectors , 2005, Gene Therapy.

[72]  T. Shimamoto,et al.  Enhanced antitumor activity in mice after administration of thermosensitive liposome encapsulating cisplatin with hyperthermia. , 1991, The Journal of pharmacology and experimental therapeutics.

[73]  V. Sinha,et al.  Microbially triggered drug delivery to the colon. , 2003, European journal of pharmaceutical sciences : official journal of the European Federation for Pharmaceutical Sciences.

[74]  Adah Almutairi,et al.  Photochemical mechanisms of light-triggered release from nanocarriers. , 2012, Advanced drug delivery reviews.

[75]  Paul Mulvaney,et al.  Surface Plasmon Spectroscopy of Nanosized Metal Particles , 1996 .

[76]  Haik Bg Advanced Coats' disease. , 1991 .

[77]  R. Magin,et al.  Temperature-dependent drug release from large unilamellar liposomes. , 1984, Cancer drug delivery.